Masayuki Otsuka

Summary

Affiliation: Chiba University
Country: Japan

Publications

  1. doi request reprint Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion
    Masayuki Ohtsuka
    Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
    Am J Surg Pathol 35:512-21. 2011
  2. ncbi request reprint [Percutaneous transhepatic portal vein stenting for portal hypertension caused by local recurrence of intrahepatic cholangiocarcinoma]
    Junichiro Kamiya
    Dept of General Surgery, Graduate School of Medicine, Chiba University
    Gan To Kagaku Ryoho 37:2726-8. 2010
  3. doi request reprint A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer
    Hideyuki Yoshitomi
    Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
    Cancer 113:2448-56. 2008
  4. pmc Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
    Seiki Miura
    Department of General Surgery, Graduate School of Medicine, Chiba University, 1 8 1, Inohana, Chuo Ku, Chiba 260 0856, Japan
    BMC Cancer 12:56. 2012
  5. ncbi request reprint Right hepatectomy combined with retrohepatic caval resection, using a left renal vein patch graft for advanced cholangiocarcinoma
    Hisashi Kurosawa
    Department of General Surgery, Chiba University Graduate School of Medicine, 1 8 1 Inohana, Chuo Ku, 260 8670, Chiba, Japan
    J Hepatobiliary Pancreat Surg 11:362-5. 2004
  6. ncbi request reprint [Portal vein stenting for portal hypertension caused by local recurrence following hepato-pancreatoduodenectomy for bile duct cancer]
    Jun Kawamoto
    Dept of General Surgery, Graduate School of Medicine, Chiba University
    Gan To Kagaku Ryoho 32:1866-9. 2005
  7. ncbi request reprint [A patient with bile duct cancer who showed rapid obstruction after insertion of a non covered stent, but in this case obtained a stent opening and better QOL after reinsertion of a covered stent]
    Seiki Miura
    Dept of General Surgery, Graduate School of Medicine, Chiba University
    Gan To Kagaku Ryoho 33:1950-2. 2006
  8. doi request reprint Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases
    Masaru Miyazaki
    Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
    Am J Surg 196:125-9. 2008
  9. doi request reprint Clinical implications of unusual NeuroD and mASH1 expression in a patient with primary large-cell neuroendocrine carcinoma of the duodenum: report of a case
    Seiki Miura
    Department of General Surgery, Chiba University Graduate School of Medicine, 1 8 1 Inohana, Chuo Ku, Chiba, 260 8670, Japan
    Surg Today 38:857-61. 2008
  10. ncbi request reprint Partial splenic embolization for the treatment of hereditary spherocytosis
    Fumio Kimura
    Department of General Surgery, Chiba University Graduate School of Medicine, 1 8 1 Inohana, Chuo Ku, Chiba 260 8670, Japan
    AJR Am J Roentgenol 181:1021-4. 2003

Collaborators

Detail Information

Publications11

  1. doi request reprint Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion
    Masayuki Ohtsuka
    Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
    Am J Surg Pathol 35:512-21. 2011
    ..In conclusion, IPNB-M showed striking similarities to IPMN-P, but IPNB-NM contained heterogeneous disease groups...
  2. ncbi request reprint [Percutaneous transhepatic portal vein stenting for portal hypertension caused by local recurrence of intrahepatic cholangiocarcinoma]
    Junichiro Kamiya
    Dept of General Surgery, Graduate School of Medicine, Chiba University
    Gan To Kagaku Ryoho 37:2726-8. 2010
    ..Our experience suggests that stent placement for postoperative PV stenosis is recommended as a useful treatment for gastrointestinal bleeding caused by portal hypertension that is less invasive...
  3. doi request reprint A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer
    Hideyuki Yoshitomi
    Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
    Cancer 113:2448-56. 2008
    ..There have been few randomized studies of adjuvant chemotherapy using gemcitabine (GEM) in patients with resected pancreatic cancer...
  4. pmc Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
    Seiki Miura
    Department of General Surgery, Graduate School of Medicine, Chiba University, 1 8 1, Inohana, Chuo Ku, Chiba 260 0856, Japan
    BMC Cancer 12:56. 2012
    ..FGF19, a member of the FGF family, has unique specificity for its receptor FGFR4. This study aimed to clarify the involvement of FGF19 in the development of HCC...
  5. ncbi request reprint Right hepatectomy combined with retrohepatic caval resection, using a left renal vein patch graft for advanced cholangiocarcinoma
    Hisashi Kurosawa
    Department of General Surgery, Chiba University Graduate School of Medicine, 1 8 1 Inohana, Chuo Ku, 260 8670, Chiba, Japan
    J Hepatobiliary Pancreat Surg 11:362-5. 2004
    ..In conclusion, major liver resection combined with caval resection and reconstruction can be performed safely. Furthermore, a left renal vein graft can provide a flexible patch according to the form and size of the caval defect...
  6. ncbi request reprint [Portal vein stenting for portal hypertension caused by local recurrence following hepato-pancreatoduodenectomy for bile duct cancer]
    Jun Kawamoto
    Dept of General Surgery, Graduate School of Medicine, Chiba University
    Gan To Kagaku Ryoho 32:1866-9. 2005
    ..Our experience suggests that the portal vein stenting using the SMART stent is useful palliative therapy for portal vein stenosis...
  7. ncbi request reprint [A patient with bile duct cancer who showed rapid obstruction after insertion of a non covered stent, but in this case obtained a stent opening and better QOL after reinsertion of a covered stent]
    Seiki Miura
    Dept of General Surgery, Graduate School of Medicine, Chiba University
    Gan To Kagaku Ryoho 33:1950-2. 2006
    ..A covered stent can be more potentially and clinically effective than a non-covered stent especially for a papillary tumor in the bile duct...
  8. doi request reprint Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases
    Masaru Miyazaki
    Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
    Am J Surg 196:125-9. 2008
    ..The purpose of this study was to show the surgical procedure and the usefulness of extensive hilar bile duct resection using a transhepatic approach for patients with hilar bile duct diseases...
  9. doi request reprint Clinical implications of unusual NeuroD and mASH1 expression in a patient with primary large-cell neuroendocrine carcinoma of the duodenum: report of a case
    Seiki Miura
    Department of General Surgery, Chiba University Graduate School of Medicine, 1 8 1 Inohana, Chuo Ku, Chiba, 260 8670, Japan
    Surg Today 38:857-61. 2008
    ..The expression patterns of NeuroD and mASH1 suggest a favorable prognosis...
  10. ncbi request reprint Partial splenic embolization for the treatment of hereditary spherocytosis
    Fumio Kimura
    Department of General Surgery, Chiba University Graduate School of Medicine, 1 8 1 Inohana, Chuo Ku, Chiba 260 8670, Japan
    AJR Am J Roentgenol 181:1021-4. 2003
    ..We retrospectively studied the therapeutic effects of partial splenic embolization as a treatment for hereditary spherocytosis...
  11. doi request reprint Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase
    Masanori Seimiya
    Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan
    Hepatology 48:519-30. 2008
    ..4% of glypican-3 negative early HCC were able to be detected by either CHC or FTCD staining. Conclusion: Immunostaining of CHC and FTCD could make substantial contributions to the early diagnosis of HCC...